Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS – Get Rating ) CEO Bobak R. Azamian sold 8,000 shares of the business's stock in a transaction dated Wednesday, June 21st. The shares were sold at an average price of $18.63, for a total transaction of $149,040.00. Following the completion of the transaction, the chief executive officer now owns 1,023,006 shares in the company, valued at $19,058,601.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink .

https://www.dailypolitical.com/2023/06/23/tarsus-pharmaceuticals-inc-nasdaqtars-ceo-sells-149040-00-in-stock.html

#dailypolitical